Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 21, 2014; 20(47): 17756-17772
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17756
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism
Elisabetta Ceni, Tommaso Mello, Andrea Galli
Elisabetta Ceni, Tommaso Mello, Andrea Galli, Gastroenterology Unit, Department of Experimental and Clinical Biochemical Sciences, University of Florence, 50139 Florence, Italy
Elisabetta Ceni, Tommaso Mello, Andrea Galli, Center of Excellence for Research, Transfer and High Education, DENOthe, University of Florence, 50139 Florence, Italy
Andrea Galli, FiorGen Foundation, 50123 Florence, Italy
Author contributions: Ceni E, Mello T and Galli A solely contributed to this paper.
Correspondence to: Andrea Galli, MD, PhD, Gastroenterology Unit, Department of Experimental and Clinical Biochemical Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. a.galli@dfc.unifi.it
Telephone: +39-55-4271419 Fax: +39-55-4222409
Received: March 11, 2014
Revised: May 22, 2014
Accepted: August 13, 2014
Published online: December 21, 2014
Abstract

Alcohol consumption is a predominant etiological factor in the pathogenesis of chronic liver diseases, resulting in fatty liver, alcoholic hepatitis, fibrosis/cirrhosis, and hepatocellular carcinoma (HCC). Although the pathogenesis of alcoholic liver disease (ALD) involves complex and still unclear biological processes, the oxidative metabolites of ethanol such as acetaldehyde and reactive oxygen species (ROS) play a preeminent role in the clinical and pathological spectrum of ALD. Ethanol oxidative metabolism influences intracellular signaling pathways and deranges the transcriptional control of several genes, leading to fat accumulation, fibrogenesis and activation of innate and adaptive immunity. Acetaldehyde is known to be toxic to the liver and alters lipid homeostasis, decreasing peroxisome proliferator-activated receptors and increasing sterol regulatory element binding protein activity via an AMP-activated protein kinase (AMPK)-dependent mechanism. AMPK activation by ROS modulates autophagy, which has an important role in removing lipid droplets. Acetaldehyde and aldehydes generated from lipid peroxidation induce collagen synthesis by their ability to form protein adducts that activate transforming-growth-factor-β-dependent and independent profibrogenic pathways in activated hepatic stellate cells (HSCs). Furthermore, activation of innate and adaptive immunity in response to ethanol metabolism plays a key role in the development and progression of ALD. Acetaldehyde alters the intestinal barrier and promote lipopolysaccharide (LPS) translocation by disrupting tight and adherent junctions in human colonic mucosa. Acetaldehyde and LPS induce Kupffer cells to release ROS and proinflammatory cytokines and chemokines that contribute to neutrophils infiltration. In addition, alcohol consumption inhibits natural killer cells that are cytotoxic to HSCs and thus have an important antifibrotic function in the liver. Ethanol metabolism may also interfere with cell-mediated adaptive immunity by impairing proteasome function in macrophages and dendritic cells, and consequently alters allogenic antigen presentation. Finally, acetaldehyde and ROS have a role in alcohol-related carcinogenesis because they can form DNA adducts that are prone to mutagenesis, and they interfere with methylation, synthesis and repair of DNA, thereby increasing HCC susceptibility.

Keywords: Alcohol metabolism, Acetaldehyde, Reactive oxygen species, Alcoholic liver disease, Protein adducts, Hepatic stellate cells, Liver fibrosis, CYP2E1

Core tip: The goal of this article is to review the mechanisms of alcohol-mediated toxicity in parenchymal and non-parenchymal cells of the liver. Specifically, we highlight the effect of oxidative ethanol metabolites such as acetaldehyde and reactive oxygen species in the development of fat accumulation, fibrosis and deranged immune response.